AIMD - Ainos, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.14 0.07 (1.69%)	---	---	-0.11 (-2.55%)	0.07 (1.69%)	0.01 (0.24%)	0.0 (-0.11%)	0.06 (1.34%)

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Market

Earnings & Ratios

Basic EPS:: -0.21
Diluted EPS:: -0.21
Basic P/E:: -20.0476
Diluted P/E:: -20.0476
RSI(14) 1m:: 0.0
VWAP:: 4.22
RVol:: 1.4263

Events

Period	Kind	Movement	Occurred At
60m	Price increase 60m	4.44 +0.21 (+5.09%)	Oct 15 09:54
1m	Price increase 1m	4.39 +0.06 (+1.37%)	Oct 15 09:48
10m	Price increase 10m	4.35 +0.15 (+3.53%)	Oct 15 09:46
1m	Price increase 1m	4.29 +0.05 (+1.18%)	Oct 15 07:00